UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D. C. 20549

                                   FORM 10-QSB

(X)   Quarterly Report Pursuant to Section 13 or 15(d) of the Securities
      Exchange Act of 1934 For the quarterly period ended May 31, 2005

(_)   Transition Report Pursuant to Section 13 or 15(d) of the Securities
      Exchange Act of 1934

             For the transition period from _________ to ___________

                       Commission File Number: 333-111996

                               SALMON EXPRESS INC.
                               -------------------
        (Exact name of small business issuer as specified in its charter)


          Nevada                                         98-0228169
          ------                                         ----------
  (State or other jurisdiction                 (IRS Employer Identification No.)
of incorporation or organization)


                  6604 Topaz Drive, Vernon, BC, Canada, V1H 1N8
                  ---------------------------------------------
                    (Address of principal executive offices)

                                 (250) 558-0991
                                 --------------
                           (Issuer's telephone number)


       ------------------------------------------------------------------
              (Former name, former address and former fiscal year,
                         if changed since last report)

Indicate by check mark whether registrant (1) has filed all reports required to
be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934
during the preceding twelve months or for such shorter period that the
Registrant was required to file such reports, and (2) has been subject to such
filing requirements for the past 90 days. Yes [ ] No [X]

The number of shares  outstanding  of  Registrant's  common stock as of July 15,
2005 was: 15,040,000.


<PAGE>

PART I - FINANCIAL INFORMATION

Item 1. Financial Statements


                               SALMON EXPRESS INC.
                          (A Development Stage Company)


                          INTERIM FINANCIAL STATEMENTS
                                   (Unaudited)

                                  MAY 31, 2005
                            (Stated in U.S. Dollars)




<PAGE>

                               SALMON EXPRESS INC.
                          (A Development Stage Company)

                             INTERIM BALANCE SHEETS
                            (Stated in U.S. Dollars)

                                                           MAY 31    NOVEMBER 30
                                                         ----------- ----------
                                                            2005        2004
                                                         (Unaudited)  (Audited)
                                                         ----------- ----------

                        ASSETS

Current
    Cash                                                   $     --    $  4,426
                                                           ========    ========

                    LIABILITIES

                      Current
        Accounts payable and accrued liabilities           $     --    $  6,598
                                                           --------    --------

                STOCKHOLDERS' EQUITY

                    Common Stock
                     Authorized:
    50,000,000 common shares, par value $0.001 per share

                 Issued and outstanding:
                15,040,000 common shares                     15,040      15,040

               Additional paid-in capital                    26,211      19,960

  Deficit Accumulated During The Development Stage          (41,251)    (37,172)
                                                           --------    --------
                                                                 --      (2,172)
                                                           --------    --------
                                                           $     --    $  4,426
                                                           ========    ========


   The accompanying notes are an integral part of these financial statements


<PAGE>

                              SALMON EXPRESS INC.
                          (A Development Stage Company)

                        INTERIM STATEMENTS OF OPERATIONS
                                   (Unaudited)
                            (Stated in U.S. Dollars)

<TABLE>
<CAPTION>
                                                                                                     CUMULATIVE
                                                                                                    PERIOD FROM
                                                                                                     INCEPTION
                                           THREE MONTHS                      SIX MONTHS              FEBRUARY 20
                                              ENDED                            ENDED                   2003 TO
                                              MAY 31                           MAY 31                   MAY 31
                                       2005             2004            2005             2004            2005
                                   -------------   -------------   -------------   -------------     -----------
<S>                                <C>             <C>             <C>             <C>               <C>
Revenue                            $           -   $           -   $           -   $           -     $         -
                                   -------------   -------------   -------------   -------------     -----------

Expenses
     General and administrative                -             975             823           2,180          16,177
     Professional fees                         -           4,500           3,256           9,500          25,074
                                   -------------   -------------   -------------   -------------     -----------
                                               -           5,475           4,079          11,680          41,251
                                   -------------   -------------   -------------   -------------     -----------

Net Loss For The Period            $           -   $      (5,475)  $      (4,079)  $     (11,680)    $   (41,251)
                                   =============   =============   =============   =============     ===========

Net Loss Per Share, Basic and
  diluted                          $           -   $           -   $           -   $           -
                                   =============   =============   =============   =============

Weighted Average Number Of
  Common Shares Outstanding           15,040,000      15,040,000      15,040,000      15,040,000
                                   =============   =============   =============   =============
</TABLE>

    The accompanying notes are an integral part of these financial statements


<PAGE>

                               SALMON EXPRESS INC.
                          (A Development Stage Company)

                        INTERIM STATEMENTS OF CASH FLOWS
                                   (Unaudited)
                            (Stated in U.S. Dollars)

<TABLE>
<CAPTION>
                                                                                                       CUMULATIVE
                                                                                                       PERIOD FROM
                                                                                                        INCEPTION
                                                      THREE MONTHS                  SIX MONTHS         FEBRUARY 20
                                                          ENDED                       ENDED              2003 TO
                                                          MAY 31                     MAY 31               MAY 31
                                                    2005         2004          2005          2004          2005
                                                 -----------  ----------    ----------    ----------    ----------
<S>                                              <C>          <C>           <C>           <C>           <C>
Cash Flows From Operating Activities
     Net loss for the period                     $        --  $   (5,475)   $   (4,079)   $  (11,680)   $  (41,251)

Adjustments To Reconcile Net Loss To Net Cash
  Used By Operating Activities
     Accounts payable                                 (6,251)      2,500        (6,598)        2,500            --
                                                 -----------  ----------    ----------    ----------    ----------
                                                      (6,251)     (2,975)      (10,677)       (9,180)      (41,251)
                                                 -----------  ----------    ----------    ----------    ----------

Cash Flows From Financing Activities
     Loan from shareholder                             6,251                     6,251            --        16,251
     Issue of common shares for cash                      --                        --            --        25,000
                                                 -----------  ----------    ----------    ----------    ----------
                                                       6,251                     6,251            --        41,251
                                                 -----------  ----------    ----------    ----------    ----------

Decrease In Cash                                          --      (2,975)       (4,426)       (9,180)           --
                                                 -----------  ----------    ----------    ----------    ----------

Cash, Beginning Of Period                                 --       8,224         4,426        14,429            --
                                                 -----------  ----------    ----------    ----------    ----------

Cash, End Of Period                                       --       5,249            --    $    5,249    $       --
                                                 ===========  ==========    ==========    ==========    ==========

Supplemental Disclosure Of Interest And Income
  Taxes Paid
     Interest paid during the period             $        --  $       --    $       --    $       --    $       --
     Income taxes paid during the period         $        --  $       --    $       --    $       --    $       --
                                                 ===========  ==========    ==========    ==========    ==========
</TABLE>


   The accompanying notes are an integral part of these financial statements


<PAGE>


                              SALMON EXPRESS INC.
                          (A Development Stage Company)

                    INTERIM STATEMENT OF STOCKHOLDERS' EQUITY

            PERIOD FROM INCEPTION, FEBRUARY 20, 2003, TO MAY 31, 2005
                                   (Unaudited)
                            (Stated in U.S. Dollars)

<TABLE>
<CAPTION>
                                                                                             DEFICIT
                                                                                           ACCUMULATED
                                               NUMBER                        ADDITIONAL     DURING THE
                                                 OF             PAR           PAID-IN      DEVELOPMENT
                                               SHARES          VALUE          CAPITAL          STAGE         TOTAL
                                           -------------   ------------    ------------    ------------    ------------
<S>                                           <C>          <C>             <C>             <C>             <C>
Shares issued for cash (March 2003)           10,000,000   $     10,000    $     (5,000)   $         --    $      5,000
Shares issued for cash (April 2003)            1,250,000          1,250           1,250              --           2,500
Shares issued for cash (May 2003)              3,750,000          3,750           3,750              --           7,500
Shares issued for cash (July 2003)                40,000             40           9,960              --          10,000
Net loss for the period                               --             --              --         (10,571)        (10,571)
                                           -------------   ------------    ------------    ------------    ------------

Balance, November 30, 2003                    15,040,000         15,040           9,960         (10,571)         14,429

Note payable to a principal stockholder
  contributed as capital (Note 4)                     --             --          10,000              --          10,000
Net loss for the year                                 --             --              --         (26,601)        (26,601)
                                           -------------   ------------    ------------    ------------    ------------

Balance, November 30, 2004                    15,040,000         15,040          19,960         (37,172)         (2,172)

Account payable to principal stockholder
contributed as capital (Note 4)                                                   6,251                           6,251
Net loss for the six months                           --             --              --          (4,079)         (4,079)
                                           -------------   ------------    ------------    ------------    ------------

Balance, May 31, 2005                         15,040,000   $     15,040    $     26,211    $    (41,251)   $         --
                                           =============   ============    ============    ============    ============
</TABLE>

   The accompanying notes are an integral part of these financial statements


<PAGE>

                               SALMON EXPRESS INC.
                          (A Development Stage Company)

                      NOTES TO INTERIM FINANCIAL STATEMENTS

                                  MAY 31, 2005
                                   (Unaudited)
                            (Stated in U.S. Dollars)


1.    BASIS OF PRESENTATION

      The unaudited financial statements as of May 31, 2005 included herein have
      been prepared without audit pursuant to the rules and regulations of the
      Securities and Exchange Commission. Certain information and footnote
      disclosures normally included in financial statements prepared in
      accordance with United States generally accepted accounting principles
      have been condensed or omitted pursuant to such rules and regulations. In
      the opinion of management, all adjustments (consisting of normal recurring
      accruals) considered necessary for a fair presentation have been included.
      It is suggested that these financial statements be read in conjunction
      with the November 30, 2004 audited financial statements and notes thereto.

2.    NATURE OF OPERATIONS AND GOING CONCERN

      a)    Nature of Operations

      Salmon Express Inc. (the "Company") was formed and incorporated in the
      State of Nevada on February 20, 2003 and is a development stage company.
      The Company has developed a system of processing (flash freezing and
      cryo-vacuum packaging) and distribution of salmon from the North Pacific
      Ocean.

      b)    Going Concern

      Since its inception, the Company has been dependent upon the proceeds of
      stock sales from its stockholders to fund its continuing activities. In
      addition to the normal risks associated with a new business venture, there
      can be no assurance that the Company's product development will be a
      commercial success. Nor can the Company give any assurance that it will
      generate substantial revenues or that its business operations will prove
      to be profitable.

      The accompanying financial statements have been prepared assuming that the
      Company will continue as a going concern. The Company has very little
      revenue and business operations and incurred a net loss of $4,079 and
      negative cash flow from operations of $4,426 for the six months ended May
      31, 2005 and has an accumulated deficit of $41,251. These conditions raise
      substantial doubt about the Company's ability to continue as a going
      concern.

      The Company's ability to continue operations is uncertain and is dependent
      upon its ability to achieve profitability, maintain current financing and
      obtain new sources of financing. These financial statements do not include
      any adjustments to the amounts and classification of assets and
      liabilities that might be necessary should the Company be unable to
      continue operations.


<PAGE>

                               SALMON EXPRESS INC.
                          (A Development Stage Company)

                      NOTES TO INTERIM FINANCIAL STATEMENTS

                                  May 31, 2005
                                   (Unaudited)
                            (Stated in U.S. Dollars)


3.    SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES AND ORGANIZATION

      a)    Development Stage Enterprise

      The Company is a development stage enterprise as defined by Statement of
      Financial Accounting Standards (SFAS) No. 7, "Accounting and Reporting by
      Development Stage Enterprises." All losses accumulated since the inception
      of the Company have been considered as part of the Company's development
      stage activities.

      b)    Basis of Presentation of Financial Information

      The accompanying financial statements as of May 31, 2005, and for the six
      months then ended, have been prepared in conformity with accounting
      principles generally accepted in the United States of America. In the
      opinion of management, all adjustments (consisting only of normal
      accruals) considered necessary for a fair presentation have been included.

      c)    Use of Estimates

      The preparation of the financial statements in conformity with accounting
      principles generally accepted in the United States of America requires
      management to make estimates and assumptions that affect the reported
      amounts of assets and liabilities and of contingent assets and liabilities
      at the date of the financial statements and the reported amounts of
      revenues and expenses during the reporting period. Actual results could
      differ from those estimates.

      d)    Loss Per Common Share

      Net loss per common share (basic and diluted) is based on the net loss
      divided by the weighted average number of common shares outstanding during
      each period. Common stock equivalents are not included in the calculation
      of diluted loss per share, because their effect would be anti-dilutive.
      There are no common stock equivalents outstanding as of May 31, 2005 and
      2004.

      e)    Impairment of Long-Lived Assets

      In August 2001, the Financial Accounting Standards Board ("FASB") issued
      Statement of Financial Accounting Standards ("SFAS") No. 144, Accounting
      for the Impairment of Disposal of Long-Lived Assets ("Statement No. 144").
      This pronouncement superceded Statement of Financial Accounting Standards
      No. 121, Accounting for the Impairment of Long-Lived Assets and Long-Lived
      Assets to be Disposed of ("Statement No. 121") and was required to be
      adopted on January 1, 2002.


<PAGE>

                               SALMON EXPRESS INC.
                          (A Development Stage Company)

                      NOTES TO INTERIM FINANCIAL STATEMENTS

                                  May 31, 2005
                                   (Unaudited)
                            (Stated in U.S. Dollars)


3. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES AND ORGANIZATION (Continued)

      e)    Impairment of Long-Lived Assets (Continued)

      Statement No. 144 retained the fundamental provisions of Statement No. 121
      as it related to assets to be held and used and assets to be sold.
      Statement No. 144 requires impairment losses to be recorded on assets to
      be held and used by the Company when indicators of impairment are present
      and the undiscounted cash flows estimated to be generated by those assets
      are less than the carrying amount of the assets. When an impairment loss
      is required for assets to be held and used by the Company, the related
      assets are adjusted to their estimated fair value. Fair value represents
      the amount at which an asset could be bought or sold in a current
      transaction between willing parties, that is, other than a forced or
      liquidation sale.

      The estimation process involved in determining if assets have been
      impaired and in the determination of fair value is inherently uncertain
      because it requires estimates of current market yields as well as future
      events and conditions. Such future events and conditions include economic
      and market conditions, as well as availability of suitable financing to
      fund acquisition and development activities. The Company had no revenue
      producing assets as at February 28, 2005 and therefore there is no
      impairment.

      f)    Recent Accounting Pronouncements

      In April 2003, the FASB issued Statement 149, Amendment of Statement 133
      on Derivative Instruments and Hedging Activities. This statement amends
      and clarifies accounting for derivative instruments, including certain
      embedded derivatives, and for hedging activities under Statement 133.
      Statement 149 is effective for contracts entered into or modified after
      June 30, 2003. Adopting this new standard is not expected to have a
      significant impact on the Company's financial statements.

      In May 2003, the FASB issued Statement No. 150, Accounting for Certain
      Financial Instruments with Characteristics of Both Liabilities and Equity.
      The Statement requires that certain financial instruments previously
      classified as equity in statements of financial position be classified as
      liabilities. The provisions in Statement 150 are effective for financial
      instruments ended into or modified after May 31, 2003, and otherwise at
      the beginning of the first interim period beginning after June 15, 2003
      for public companies. Adopting this new standard is not expected to have a
      significant impact on the Company's financial statements.


<PAGE>

                               SALMON EXPRESS INC.
                          (A Development Stage Company)

                      NOTES TO INTERIM FINANCIAL STATEMENTS

                                  May 31, 2005
                                   (Unaudited)
                            (Stated in U.S. Dollars)


3.    SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES AND ORGANIZATION (Continued)

      f)    Recent Accounting Pronouncements (Continued)

      In November 2004, the FASB issued Statement 151, "Inventory Costs". This
      Statement amends the guidance in ARB No. 43, Chapter 4, "Inventory
      Pricing", to clarify the accounting for abnormal amounts of idle facility
      expense, freight, handling costs, and wasted material (spoilage).
      Statement 151 requires that those items be recognized as current period
      charges regardless of whether they meet the criterion of "so abnormal". In
      addition, this Statement requires that allocation of fixed production
      overheads to the costs of conversion be based on the normal capacity of
      the production facilities. Statement 151 is effective for inventory costs
      incurred during fiscal years beginning after June 15, 2005, with earlier
      application permitted in certain circumstances. Adopting this new standard
      is not expected to have a significant impact on the Company's financial
      statements.

      In December 2004, FASB has also issued SFAS No. 152 and 153 but they will
      not have any relationship to the operations of the Company, therefore, a
      description of each and their respective impact on the Company's
      operations have not been disclosed.

      g)    Fair Value of Financial Instruments

      The carrying amounts of the Company's financial instruments at May 31,
      2005, approximates their fair values.

4.    NOTE PAYABLE

      Under the terms of the proposed merger (see Note 5), the principal
      stockholder will contribute the note payable and account payable due him
      to the Company. Therefore they have been classified into equity as part of
      additional paid-in capital.

5.    MERGER AGREEMENT

      On January 31, 2005, the Board of Directors approved the following:

      i)    entering into a merger agreement with MicroMed Technology, Inc.
            effective May 1, 2005;

      ii)   reverse stock split of 1 for 3.3528 immediately prior to the merger;

      iii)  reincorporation from the State of Nevada to the State of Delaware;
            and

      iv)   a name change to "Micro Med Cardiovascular Technologies, Inc."

      Majority shareholder approval was also received on January 31, 2005.


<PAGE>

                               SALMON EXPRESS INC.
                          (A Development Stage Company)

                      NOTES TO INTERIM FINANCIAL STATEMENTS

                                  MAY 31, 2005
                                   (Unaudited)
                            (Stated in U.S. Dollars)


5.    MERGER AGREEMENT (Continued)

      Under the terms of the merger agreement, the Company will incorporate a
      subsidiary which will be merged with MicroMed Technology, Inc.
      ("MicroMed"). Each issued and outstanding share of common stock of the
      subsidiary will be converted into one issued share of the surviving
      corporation. Each fully issued share of MicroMed common stock outstanding
      will be converted into one issued share of the Company's common stock.
      Warrants to purchase shares of MicroMed common stock and options to
      purchase shares of MicroMed common stock outstanding immediately prior to
      the effective date will be assumed by the Company and will become warrants
      to purchase shares of the Company's common stock or options to purchase
      shares of the Company's common stock, as applicable. The shares of the
      Company owned by the current majority shareholder will be cancelled and
      all the pre-merger assets and liabilities will be transferred to that
      shareholder.

      At May 31, 2005 the merger had not yet been completed. It is management's
      belief that the merger will be completed.

      On May 16, 2005, the merger agreement was amended to extend the
      termination date of the merger to July 31, 2005.

      On July 29, 2005, the merger agreement was amended again to extend the
      termination date of the merger to August 31, 2005.

Item 2. Management's Discussion and Analysis or Plan of Operations

Plan of Operation

Salmon sale operations have been substantially halted in anticipation of the
merger with Micromed (discussed above, under note 5 to the financial statements,
and discussed in more detail below). As noted, we fully anticipate the merger to
occur in the very near future. However, should the merger not occur for whatever
reason, we are prepared to continue with operations focusing on Salmon product
sales. Before entering merger discussions, we attempted to implement our three
streams for generating revenue: the sale and delivery of salmon products through
our website salmonx.com; the sale and delivery of salmon products through our
1-800 phone line; and the sale and delivery of other seafood products when in
season through both the web site and the 1-800 phone line. We have established
distribution channels to meet any orders we receive. In the future, we may
obtain cold storage space (suitable for holding flash frozen seafood products)
and establish an inventory of Salmon Express products. Ultimately, once we can
predict demand, establishing an inventory will improve our ability to obtain
whole-sale prices for seafood products and make quality control and delivery
more efficient. We intend to maintain good relationships with a number of salmon
suppliers in our target geographic region so that our inventory can be
maintained, diminished or increased depending on initial consumer response.

We have been sending brochures to our niche customers. These brochures highlight
the superior quality of our product, the products available, ordering
information and prices. We also market Salmon Express products through our
internet web-site, which uses pictures, slogans and various search engine hit
maximization strategies to market our product platform.


<PAGE>

Funds received from our private offerings have provided us with enough funds to
execute the initial stages of our business plan which includes the initial
development of our internet web site and 1-800 ordering service, our product and
logo development, development of key products, and the ongoing establishment of
distribution agreements with key high-end salmon distributors. Under currently
anticipated budgetary constraints, and assuming we fail to generate any revenues
in our first year of operations, we anticipate that we can maintain an
operational Internet web site, being Salmonx.com, an operational 1-800 number
service, distribution channels with high quality salmon products distributors,
and keep several Salmon Express products available, in various packaging
schemes, for order and fast delivery with very little initial capital outflow
required. We will, however, if the Micromed merger does not happen, be required
to borrow funds from our president, Peter Smith, to re-initiate these
operations.

Our marketing efforts to date have yielded little if any results. Unless our
marketing becomes more effective than it has been to date, we will be forced to
close the business or find more effective ways of conducting our business.

In light of the lack of results to our marketing efforts to date, our President
has initiated discussions with MicroMed Technology, Inc. ("MicroMed"), a
privately held Delaware corporation based in Houston, Texas, to merge a
subsidiary of Salmon with and into MicroMed, with MicroMed as the surviving
entity at the subsidiary level. We will issue shares of our common stock on a
one-for-one basis to the stockholders of MicroMed in exchange for 100% of the
issued and outstanding shares of common stock of MicroMed. Additionally, we will
assume options to purchase shares of common stock and warrants to purchase
shares of common stock on the same terms and conditions as previously issued by
MicroMed. All outstanding options that will be assumed by us have been issued
under the MicroMed 1997 Stock Option Plan or the MicroMed 2005 Stock Incentive
Plan. Further to the Merger, we will assume the MicroMed 1997 Stock Option Plan
and the MicroMed 2005 Stock Incentive Plan as stock option plans of our company.
We will also issue 1,500,000 post-split shares into escrow to cover
indemnification obligations, if any, to MicroMed and its stockholders.

Immediately prior to the Merger, we will effectuate a 1-for-3.3528 reverse stock
split of our common stock. After the Merger is concluded, we will reincorporate
from the State of Nevada to the State of Delaware and change our corporate name
to MicroMed Cardiovascular, Inc., or such other name as MicroMed may select
prior to closing. Further to the Merger, we will also cancel 10,010,800 shares
of our pre-split common stock held by Pete Smith and distribute assets, and
related liabilities, to him that we held prior to the Merger. Mr. Smith will
also receive cash remuneration of $605,213 from third parties unaffiliated with
us for his agreement to cancel such shares. On February 3, 2005, March 30, 2005,
and May 11, 2005, respectively, we filed a form PREM14C, a form PRER14C and a
form DEF14C with the Securities Exchange Commission of the United States
pursuant to a proposed Agreement and Plan of Merger with MicroMed. We also filed
a supplement to our DEF14C on June 24, 2005.

MicroMed is a medical device company focused on the development of ventricular
assist device ("VAD") products. MicroMed has developed a miniaturized heart
pump, or VAD, known as the DeBakey VAD (the "DeBakey VAD") to address congestive
heart failure, a condition where the diseased heart cannot pump adequate blood
to meet the oxygen and nutritional needs of the body. The DeBakey VAD is a small
(1 inch x 3 inches) National Aeronautics and Space Administration designed axial
flow pump that can provide increased blood flow from the left ventricle of the
heart throughout the body for patients whose hearts are diseased and unable to
maintain adequate blood flow to sustain their lives.


<PAGE>

Liquidity

To jump start our business plan and to operate our business for the next 12
months, if the discussed merger with Micromed does not happen, we believe we
will need approximately $50,000. We plan on obtaining this operating capital
from our own available funds, and we expect to raise capital through the sale of
equity capital if business revenues are not available to pay necessary expenses.
However, if funds are not available from these sources, our director and
President, Mr. Pete Smith has agreed to loan Salmon Express up to $50,000 in
furtherance of our plan of operations for the next twelve months. We do not
anticipate the need for any additional employees during the next twelve months
other than the services of the individuals discussed above, unless initial
response to our products is extremely positive and orders are more numerous than
expected.

Going Concern

The accompanying financial statements have been prepared assuming that the
Company will continue as a going concern. The Company has very little revenue
and business operations and incurred a net loss of $4,079 and negative cash flow
from operations of $4,426 for the six month period ended May 31, 2005, and net
loss of $26,601 for the year ended November 30, 2004. These conditions raise
substantial doubt about the Company's ability to continue as a going concern.

Funds received from the Company's private offerings have provided the Company
with enough funds to execute the initial stages of the Company's business plan
which includes the initial development of the Company's internet web site and
1-800 ordering service, the Company's product and logo development, development
of key products, and the ongoing establishment of distribution agreements with
key high-end salmon distributors in the region the Company intends to market.
Under currently anticipated budgetary constraints, and assuming the Company
fails to generate any revenues in its first year of operation commencing in the
fourth quarter of 2004, the Company anticipates that it will have an operational
Internet web site, being Salmonx.com, an operational 1-800 number service,
distribution channels established with high quality salmon products
distributors, and several Salmon Express products available, in various
packaging schemes, for order and fast delivery. We will, however, if the
Micromed merger does not happen, be required to borrow funds from our president,
Peter Smith, to re-initiate these operations. For further information relevant
to the Company's ability to continue as a going concern, see section "Liquidity"
above.

                           Forward-Looking Statements:

Many statements made in this report are forward-looking statements that are not
based on historical facts. Because these forward-looking statements involve
risks and uncertainties, there are important factors that could cause actual
results to differ materially from those expressed or implied by these
forward-looking statements. The forward-looking statements made in this report
relate only to events as of the date on which the statements are made.

Recent Accounting Pronouncements

In January 2003, (as revised in December 2003) The Financial Accounting
Standards Board ("FASB") issued Interpretation No. 46, "Consolidation of
Variable Interest Entities", an interpretation of Accounting Research Bulletin
("ARB") No. 51, "Consolidated Financial Statements". Interpretation No. 46
addresses consolidation by business enterprises of variable interest entities,
which have one or both of the following characteristics: (i) the equity
investment at risk is not sufficient to permit the entity to finance its
activities without additional subordinated support from other parties, which is
provided though other interest that will absorb some or all of the expected
losses of the entity: (ii) the equity investors lack one or more of the
following essential characteristics of a controlling financial interest: the
direct or indirect ability to make decisions about the entities activities
through voting rights or similar rights; or the obligation to absorb the
expected losses of the entity if they occur, which makes it possible for the
entity to finance its activities; the right to receive the expected residual
returns of the entity if they occur, which is the compensation for the risk of
absorbing the expected losses.


<PAGE>

Interpretation No. 46, as revised, also requires expanded disclosures by the
primary beneficiary (as defined) of a variable interest entity and by an
enterprise that holds a significant variable interest entity and by an
enterprise that holds a significant variable interest in a variable interest
entity but is not the primary beneficiary.

Interpretation No. 46, as revised, applies to small business issuers no later
than the end of the first reporting period that ends after December 15, 2004.
This effective date included those entities to which Interpretation No. 46 has
previously been applied. However, prior to the required application of
Interpretation No. 46, a public entity that is a small business issuer shall
apply purpose entities no later than as of the end of the first reporting period
that ends after December 15, 2003.

Interpretation No. 46 may be applied prospectively with a cumulative-effect
adjustment as of the date on which it is first applied or by restating
previously issued financial statements for one or more years with a
cumulative-effect adjustment as of the beginning of the first year restated.

In June 2003, the FASB issued an Exposure Draft for a proposed SFAS entitled
"Qualifying Special Purpose Entities ("QSPE") and Isolation of Transferred
Assets", an amendment of SFAS No. 140 ("The Exposure Draft"). The Exposure Draft
is a proposal that is subject to change and as such is not yet authoritative. If
the proposal is enacted in its current form, it will amend and clarify SFAS 140.
The Exposure Draft would prohibit an entity from being a QSPE if it enters into
an agreement that obligated a transferor of financial assets, its affiliates or
its agents to deliver additional cash or other assets to fulfill the
special-purposes entity's obligation to beneficial interest holders.

In April 2003, the FASB issued SFAS No. 149, "Amendment of Statement 133 on
Derivative Instruments and Hedging Activities". SFAS No. 149 amends and
clarifies financial accounting reporting for derivative instruments, including
certain derivative instruments embedded in other contracts (collectively
referred to as derivatives) and for hedging activities under SFAS No. 133,
"Accounting for Derivative Instruments and Hedging Activities". The changes in
SFAS No. 149 improve financial reporting by requiring that contracts with
comparable characteristics be accounted for similarly. This statement is
effective for contracts entered into or modified after June 30, 2003 and all of
its provisions should be applied prospectively.

In May 2003, the FASB issued SFAS No. 150, "Accounting for Certain Financial
Instruments with Characteristics of both Liabilities and Equity". SFAS No. 150
changes the accounting for certain financial instruments with characteristics of
both liabilities and equity that, under previous pronouncements, issuers could
account for as equity. The new accounting guidance contained in SFAS No. 150
requires that those instruments be classified as liabilities in the balance
sheet.

SFAS No. 150 affects the issuer's accounting for three types of freestanding
financial instruments. One type is mandatory redeemable shares, which the
issuing company is obligated to buy back in exchange for cash and other assets.
A second type includes put options and forward purchase contracts, which involve
instruments that do or may require the issuer to buy back some of its shares in
exchange for cash or other assets. The third type of instruments that are
liabilities under this Statement is obligations that can be settled with shares,
the monetary value of which is fixed, tied solely or predominantly to a variable
such as a market index, or varies inversely with the value of the issuer's
shares.


<PAGE>

SFAS No. 150 does not apply to features embedded in a financial instrument that
is not a derivative in its entirety. Most of the provisions of Statement 150 are
consistent with the existing definition of liabilities in FASB Concepts
Statements No. 6, "Elements of Financial Statements". The remaining provisions
of this Statement are consistent with the FASB's proposal to revise that
definition to encompass certain obligations that a reporting entity can or must
settle by issuing its own shares. This Statement shall be effective for
financial instruments entered into or modified after May 31, 2003 and otherwise
shall be effective at the beginning of the first interim period beginning after
June 15, 2003, except for mandatory redeemable financial instruments of a
non-public entity, as to which the effective date is for fiscal periods
beginning after December 15, 2003.

Management does not expect the implementation of these recent pronouncements to
have a material effect on the Company's financial position of results of
operations.

Item 3. Controls and Procedures.

As of the end of the period covered by this report, Management carried out an
evaluation of the effectiveness of the design and operation of the Company's
disclosure controls and procedures, pursuant to Exchange Act Rule 13a-15(b) and
15d-15(b) which includes inquiries made to certain other of our employees. Based
on the foregoing, the Principal Executive Officer and Principal Financial
Officer concluded that the Company's disclosure controls and procedures are
effective to timely alert them to any material information relating to the
Company that must be included in the Company's' periodic SEC filings. In
addition, there have been no changes in the Company' internal controls over
financial reporting that occurred during the fiscal quarter covered by this
quarterly report that has materially affected, or is reasonably likely to
materially affect, the Company's internal control over financial reporting.

PART II - OTHER INFORMATION

Item 1. Legal Proceedings

We are not currently a party to any legal proceedings.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.

None.

Item 3.  Defaults Upon Senior Securities

None.

Item 4. Submission of Matters to a Vote of Securities Holders

On February 3, 2005, March 30, 2005, and May 11, 2005, respectively, we filed a
form PREM14C, a form PRER14C and a form DEF14C with the Securities Exchange
Commission of the United States pursuant to a proposed Agreement and Plan of
Merger (the "Merger Agreement") with MicroMed Technology, Inc. ("MicroMed"), a
privately held Delaware corporation based in Houston, Texas. Subsequently, we
also filed a supplement to our DEF14C on June 24, 2005. The Merger is to be


<PAGE>

accomplished through our wholly-owned merger subsidiary in Nevada ("Merger
Sub"), which will merge with and into MicroMed, with MicroMed being the
survivor. We will issue shares of our common stock on a one-for-one basis to the
stockholders of MicroMed in exchange for 100% of the issued and outstanding
shares of common stock of MicroMed. Additionally, we will assume options to
purchase shares of common stock and warrants to purchase shares of common stock
on the same terms and conditions as previously issued by MicroMed. All
outstanding options that will be assumed by us have been issued under the
MicroMed 1997 Stock Option Plan or the MicroMed 2005 Stock Incentive Plan.
Further to the Merger, we will assume the MicroMed 1997 Stock Option Plan and
the MicroMed 2005 Stock Incentive Plan as stock option plans of Salmon. We will
also issue 1,500,000 post-split shares into escrow to cover indemnification
obligations, if any, to MicroMed and its stockholders. Immediately prior to the
Merger, we will effectuate a 1-for-3.3528 reverse stock split of our common
stock (the "Stock Split"). After the Merger is concluded, we will reincorporate
from the State of Nevada to the State of Delaware (the "Reincorporation") and
change our corporate name to MicroMed Cardiovascular, Inc., or such other name
as MicroMed may select prior to closing (the "Name Change"). Further to the
Merger, we will also cancel 10,010,800 shares of our pre-split common stock held
by Pete Smith and distribute assets, and related liabilities, to him that we
held prior to the Merger.

The Merger will result in a change-in-control of Salmon by MicroMed's management
and its stockholders and the assumption of MicroMed's operations and
liabilities.

Because the contemplated Merger is to be accomplished by the Merger Sub, a vote
by our stockholders was not required by the Nevada Revised Statutes. However,
because members of our Board of Directors are interested parties to the Merger,
we obtained the written consent of the holders of a majority of our common
stock.

The affirmative vote of the holders of a majority of our outstanding voting
stock is sufficient to effectuate the Stock Split. The Nevada Revised Statute
provides that any action which may be taken at a meeting of the stockholders may
be taken without a meeting and without prior notice, if a consent in writing,
setting forth the action so taken, shall be signed by the holders of a majority
of the outstanding shares entitled to vote.

On January 31, 2005, there were 15,040,000 shares of common stock outstanding.
The holders of our common stock are entitled to one vote for each share held of
record on all matters submitted to a vote of our stockholders. Thus, we needed
the affirmative vote of 7,520,001 shares to approve the Stock Split. By action
of written consent, dated January 31, 2005, holders of a majority of our
outstanding shares of common stock approved the Stock Split. As a result,
adoption of the Stock Split was approved and no further votes will be needed.

The affirmative vote of the holders of a majority of our outstanding voting
stock is sufficient to effectuate the Name Change and the Reincorporation. The
Nevada Revised Statute provides that any action which may be taken at a meeting
of the stockholders may be taken without a meeting and without prior notice, if
a consent in writing, setting forth the action so taken, shall be signed by the
holders of a majority of the outstanding shares entitled to vote.

On January 31, 2005, there were 15,040,000 shares of common stock outstanding.
The holders of our common stock are entitled to one vote for each share held of
record on all matters submitted to a vote of our stockholders.

Thus, we needed the affirmative vote of 7,520,001 shares to approve the Name
Change and the Reincorporation. By action of written consent, dated January 31,
2005, holders of a majority of our outstanding shares of common stock approved
the Name Change and the Reincorporation. As a result, adoption of the Name
Change and the Reincorporation was approved and no further votes will be needed.


<PAGE>

The Merger will not be effective until the Articles of Merger and Certificate of
Merger are filed with the Nevada Secretary of State and the Delaware Secretary
of State, as applicable. The Stock Split will not be effective until we file a
Certificate of Amendment to Articles of Incorporation with the Nevada Secretary
of State. The Reincorporation and the Name Change will not be effective until we
file a Certificate of Incorporation with the Delaware Secretary of State and an
Agreement and Plan of Merger with the Nevada Secretary of State and the Delaware
Secretary of State.

Item 5. Other Information.

As previously disclosed on a current report on Form 8-K filed on February 1,
2005, we entered into an Agreement and Plan of Merger dated January 31, 2005, by
and among the our company, MicroMed, Salmon Acquisition Corp., a privately-held
Nevada corporation and wholly-owned subsidiary of our company (the "Merger
Sub"), and Pete Smith.

On May 16, 2005, the parties entered into a First Amendment to Agreement and
Plan of Merger, which extends the termination date of the merger to July 31,
2005.

Item 6. Exhibits and Reports on Form 8-K.

(a)   Exhibits

      2.1   First Amendment to Agreement and Plan of Merger, dated as of May 16,
            2005, by and among Salmon Express, Inc., MicroMed Technology, Inc.,
            Salmon Acquisition Corp. and Pete Smith, Sr.

      31.1  Certification of CEO and CFO pursuant to Securities Exchange Act
            rules 13a-15 and 15d-15(c) as adopted pursuant to section 302 of the
            Sarbanes-Oxley act of 2002.

      32.1  Certification of CEO and CFO pursuant to 18 U.S.C. section 1350, as
            adopted pursuant to section 906 of the Sarbanes-Oxley act of 2002.*

* This exhibit shall not be deemed "filed" for purposes of Section 18 of the
Securities Exchange Act of 1934 or otherwise subject to the liabilities of that
section, nor shall it be deemed incorporated by reference in any filing under
the Securities Act of 1933 or the Securities Exchange Act of 1934, whether made
before or after the date hereof and irrespective of any general incorporation
language in any filings.


(b) Reports on Form 8-K.

On March 21, 2005, the Registrant filed its amended report on Form 8-K/A
disclosing its change in certifying accountant under item 4.01.


                                   SIGNATURES

In accordance with the requirements of the Exchange Act, the registrant caused
this report to be signed on its behalf by the undersigned, thereunto duly
authorized.

SALMON EXPRESS INC.


By:      /s/ Pete Smith
         ------------------------------
         Pete Smith
         CEO and CFO
         (Principal Executive Officer)
         (Principal Financial Officer)
         (Principal Accounting Officer)

         Date:      August 3, 2005